A novel report in the Journal of Bone and Mineral Research describes the aggressiveness of primary hyperparathyroidism associated with multiple endocrine neoplasia type 1 (MEN1) syndrome on kidney and bone complications. Will these findings influence the future management of parathyroid disease in patients with MEN1 syndrome?
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Wermer, P. Genetic aspects of adenomatosis of endocrine glands. Am. J. Med. 16, 363–371 (1954).
Brandi, M. L. et al. Guidelines for diagnosis and therapy of MEN 1 type 1 and type 2. J. Clin. Endocrinol. Metab. 86, 5658–5671 (2001).
Brandi, M. L., Marx, S. J., Aurbach, G. D. & Fitzpatrick, L. A. Familial multiple endocrine neoplasia type 1: a new look at pathophysiology. Endocr. Rev. 4, 391–405 (1987).
Doherty, G. M. et al. Lethality of multiple endocrine neoplasia type I. World J. Surg. 22, 581–587 (1998).
Lourenço, D. M. Jr et al. Early-onset, progressive, frequent, extensive and severe bone mineral and renal complications in multiple endocrine neoplasia type 1-associated primary hyperparathyroidism. J. Bone Miner. Res. doi:10.1002/jbmr.125.
Burgess, J. R., David, R. Greenaway, T. M., Parameswaran, V. & Shepherd, J. J. Osteoporosis in multiple endocrine neoplasia type 1: severity, clinical significance, relationship to primary hyperparathyroidism, and response to parathyroidectomy. Arch. Surg. 134, 1119–1123 (1999).
Lourenço, D. M. Jr et al. Multiple endocrine neoplasia type 1 in Brazil: MEN1 founding mutation, clinical features, and bone mineral density profile. Eur. J. Endocrinol. 159, 259–274 (2008).
Coutinho, F. L. et al. Bone mineral density analysis in patients with primary hyperparathyroidism associated with multiple endocrine neoplasia type 1 after total parathyroidectomy. Clin. Endocrinol. (Oxf.). 72, 462–468 (2010).
Christopoulos, C., Antoniou, N., Thempeyioti, A., Calender, A. & Economopoulos, P. Familial multiple endocrine neoplasia type I: the urologist is first on the scene. BJU Int. 96, 884–887 (2005).
Tham, E. et al. Clinical testing for mutations in the MEN1 gene in Sweden: A report on 200 unrelated cases. J. Clin. Endocrinol. Metab. 92, 3389–3395 (2007).
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares an association with the following companies: Amgen (consultant; grant/research support), Eli Lilly (grant/research support), Merck, Sharp and Dohme (consultant), Novartis (consultant; grant/research support), Sevier (consultant; grant/research support), Warner Chilcott (grant/research support).
Rights and permissions
About this article
Cite this article
Brandi, M. Hyperparathyroidism in MEN1 syndrome: time to operate?. Nat Rev Endocrinol 6, 604–605 (2010). https://doi.org/10.1038/nrendo.2010.131
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrendo.2010.131
